Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$15,308,803
+$9,805,726 QoQ
Shares Held
60,278
+167.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#873
of 4,664 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Turtle Creek Wealth Advisors, LLC holds $73,913,810 across 10 Drug Manufacturers - General names. JNJ ranks #2 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,818 | $33,365,746 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
60,278 | $15,308,803 | |
| 3 | AZN |
Astrazeneca PLC
|
38,731 | $7,344,172 | |
| 4 | ABBV |
AbbVie Inc.
|
28,533 | $7,180,044 | |
| 5 | MRK |
Merck & Co., Inc.
|
28,968 | $3,722,388 | |
| 6 | AMGN |
Amgen Inc
|
9,709 | $3,515,823 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
13,235 | $1,672,109 | |
| 8 | PFE |
Pfizer Inc
|
36,870 | $887,829 |
All Filings in JNJ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,308,803 | 60,278 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $5,503,077 | 22,513 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $4,125,548 | 19,935 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $3,342,566 | 18,027 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,224,138 | 8,014 | Shares | Sole | 2025-07-28 | |
| 2024-09-30 | $905,591 | 5,588 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $762,370 | 5,216 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $654,906 | 4,140 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $430,408 | 2,746 | Shares | Sole | 2024-01-26 | |
| No filing history on record for this holder in this stock. | ||||||